TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 102 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q1 2016. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $130,000 | +62.5% | 28,368 | +257.0% | 0.00% | – |
| Q4 2015 | $80,000 | -23.1% | 7,946 | -42.8% | 0.00% | – |
| Q3 2015 | $104,000 | -68.9% | 13,898 | +97.6% | 0.00% | – |
| Q2 2015 | $334,000 | +42.1% | 7,032 | +9.5% | 0.00% | – |
| Q1 2015 | $235,000 | +193.8% | 6,423 | +218.8% | 0.00% | – |
| Q4 2014 | $80,000 | -80.7% | 2,015 | -93.4% | 0.00% | – |
| Q2 2014 | $414,000 | +106.0% | 30,670 | +73.4% | 0.00% | – |
| Q3 2013 | $201,000 | – | 17,690 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 664,000 | $2,543,000 | 0.82% |
| GREAT POINT PARTNERS LLC | 452,375 | $1,733,000 | 0.44% |
| Clearline Capital LP | 267,915 | $1,026,000 | 0.32% |
| Rhenman & Partners Asset Management AB | 300,000 | $1,149,000,000 | 0.18% |
| Rock Springs Capital Management LP | 662,500 | $2,537,000 | 0.16% |
| Eventide Asset Management | 600,000 | $2,298,000 | 0.14% |
| Granahan Investment Management | 657,496 | $2,518,000 | 0.08% |
| Candriam S.C.A. | 374,000 | $1,432,000 | 0.03% |
| Tekla Capital Management LLC | 192,322 | $737,000 | 0.03% |
| DOW CHEMICAL CO /DE/ | 65,000 | $249,000 | 0.02% |